Retinal Biologics Global Market Report 2023: Innovations Key to Future Advances - Long-term Forecasts to 2028 and 2033
January 25, 2024 09:33 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Retinal Biologics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. Profound analytics indicate that the...
Retinal Biologics Market to Reach $24.7 Billion, Globally, by 2032 at 5.1% CAGR: Allied Market Research
July 13, 2023 09:31 ET
|
Allied Market Research
Portland, OR, July 13, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Retinal Biologics Market By Drug Class (VEGF-A Antagonist and Others), By Indication, (Macular...
Retinal Biologics Market to hit US $18.3 billion by 2028 - Global Insights on Trends, Growth Drivers, Investment Plans, Expansion Analysis, COVID-18 Impact, Key Players and Future Opportunities: Adroit Market Research
January 14, 2021 05:22 ET
|
Adroit Market Research
Dallas, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The global retinal biologics market is projected to grow at a CAGR of 6.5%. Increasing prevalence of retinal disorders such as macular degeneration,...